Tris Pharma Announces Appointment of Dr. Mahdi Fawzi as Top R&D Executive
(January, 2012)
Tris Pharma Announces US Patent Grant Covering Platform Technology
(January, 2012)
Tris Pharma Expands Leadership Team, Adds Senior Managers in Quality and Finance
(August, 2011)
Tris Pharma Appoints Vice President of Human Resources
(June, 2011)
Tris Pharma Announces Availability of the MyKidz® Iron Product Line - the Best Tasting Iron Supplements (March, 2011)
Tris Announces NDA Acceptance of Extended Release Carbinoxamine Oral Suspension for the Treatment of Allergies in Kids Two Years and Older
(March, 2011)
NextWave Pharmaceuticals Announces Launch of NEXICLON XR – First Extended-Release, Once-Daily Clonidine Oral Suspension
and Tablet (January, 2011)
Tris Pharma Announces Approval of First-Ever Generic of Tussionex® Extended-Release Suspension
(October, 2010)
Par Pharmaceutical Begins Limited Shipment of Generic Tussionex®
(October, 2010)
NextWave Pharmaceuticals and Tris Pharma Enter into CNS-focused Development and Commercialization Agreement
(August, 2010)
Tris Pharma Announces Approval of First-Time Generic of Methylphenidate Hydrochloride Oral Solution With Six Months Exclusivity
(July, 2010)
Perrigo Acquires Exclusive Sales and Distribution Rights to Generic Version of Delsym(R) from Tris Pharma
(May, 2010)
Tris Pharma Announces Key Executive Hiring of Vice President of Corporate Development (April, 2010)
Tris Pharma Announces Two NDA Approvals from FDA including a Pioneering, First-Ever 24 hour Liquid Sustained Release Product (Dec, 2009)
FDA Accepts Tris Pharma's ANDA with Paragraph IV certification for a generic equivalent to Delsym (July, 2009)
Tris Pharma Announces Acceptance of Its First Two NDAs (May, 2009)
Tris Pharma's New Tool Fights Against Prescription Drug Abuse (November, 2008)
Tris Pharma Completes Its Facilities' Expansion, Receives FDA Clearance (September, 2008)
Edison Innovation Fund Helps Tris Pharma Expand (November, 2007)
Industry Veteran Timothy Saxon Joins Tris Pharma as Vice President, Business Development (November, 2007)
Alpharma licenses novel technology from Tris Pharma (March 29, 2007)
Tris Pharma Unveils Expansion of State-Of-The-Art-Research Facility (October 16, 2006)
Tris Pharma to exhibit at the 2006 AAPS Annual Meeting and Exposition from October 29 - November 2. This year's
show will be at the Henry B. Gonzalez Convention Center in San Antonio, TX.
Interpharm Announces Agreements with Tris Pharma to Expand New Product Development; Collaboration on 32 Products, Including 25 Liquid Products (March 02, 2005)
Tris Expands, Adds Jobs with Second EDA Financing (January 26, 2004)
Tris Pharma Moves to South Brunswick; State program helps finance firm’s growth – as reported in the Sentinel Newspaper, East Brunswick, NJ (May 09, 2002)